Novo Nordisk is seeking FDA approval for an experimental obesity shot, CagriSema (cagrilintide and semaglutide), according to a Dec. 18 news release from the Denmark-based drugmaker. CagriSema is a weekly injection of semaglutide, a GLP-1, and cagrilintide, a long-acting amylin…
Pharmacy
After a UCI Health pharmacy pilot exceeded its goal $1.1 million in gross margin by an additional $300,000, the Orange, Calif.-based system approved a $30 million expansion of the project. Melanie Joe, PharmD, chief pharmacy officer at UCI Health, a…
The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive list. Listings were compiled from job-seeker websites.
The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients ages 12 and older. The approval is based on data from the drugmaker’s SWIFT-1 and SWIFT-2 trials, which showed…
The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update applies to Depo-Provera CI…
Advertisement
Healthcare is continuously evolving. And with that comes increasing complexity – fragmented care, staffing challenges, cybersecurity concerns, inventory visibility gaps, and regulatory pressures, just to name a few. Today’s systems can create silos across the care continuum, keeping pharmacists and…
Will Carroll, PharmD, has joined Sacramento, Calif.-based Sutter Health as vice president and chief pharmacy officer after three years at Edison, N.J.-based Hackensack Meridian Health. Dr. Carroll assumed his new role Nov. 3, according to a spokesperson for the 27-hospital…
Ultra high-cost drugs, or medications that cost more than $1 million per patient, can be life-altering treatments. They are also covered in an obsolete payment system, according to Mike Evans, RPh, chief pharmacy officer for Danville, Pa.-based Geisinger. “Every year,…
The FDA has issued a supplemental biologics license application to teclistamab, a Johnson & Johnson therapy, to participate in its National Priority Voucher pilot program, according to Dec. 15 news releases from the agency and the company. The application is…
CVS Caremark reached a settlement exceeding $5 million over allegations of pharmacy underpayments, according to a Dec. 8 news release from Oklahoma Attorney General Gentner Drummond. The money will go to pharmacies that filled 68,099 eligible prescriptions between January 2024…